Table 1 The correlation between clinical characteristics and CDH4 mRNA expression in lung cancer tissue
Variable | N | CDH4 mRNA | P |
|---|---|---|---|
Median (mean, range) | |||
Gender | 0.137 | ||
Female | 28 | 0.088(0.190, 0.019–1.367) | |
Male | 114 | 0.075(0.141, 0.012–2.661) | |
Age | 0.539 | ||
<65 | 99 | 0.080(0.167, 0.013–2.661) | |
≥65 | 43 | 0.074(0.115, 0.012–0.517) | |
Grade | 0.013* | ||
“High”–“middle” | 71 | 0.068(0.119,0.012-0.932) | |
“Middle-low”–“low” | 63 | 0.108(0.197,0.013-2.661) | |
Censoring | 8 | 0.053(0.071,0.022-0.175) | |
Histotype | 0.001* | ||
Squamous | 77 | 0.067(0.116, 0.012–1.367) | |
Adenocarcinoma | 58 | 0.125(0.203, 0.013–2.661) | |
Others | 3 | 0.084(0.096, 0.081–0.125) | |
SCLC | 4 | 0.108(0.106,0.069-0.139) | |
Lymph node metastasis | 0.733 | ||
0 | 69 | 0.092(0.161, 0.012–1.367) | |
1 | 21 | 0.067(0.113, 0.013–0.408) | |
2–3 | 26 | 0.073(0.187, 0.016–2.661) | |
4–24 | 24 | 0.086(0.120, 0.020–0.517) | |
Censoring | 2 | 0.100(0.100, 0.078–0.123) | |
Stage | 0.580 | ||
I–II | 96 | 0.082(0.172, 0.012–2.661) | |
III–IV | 46 | 0.079(0.106, 0.020–0.517) | |
Family history | 0.404 | ||
Yes | 25 | 0.070(0.115, 0.012–0.666) | |
No | 105 | 0.083(0.167, 0.013–2.661) | |
Censoring | 12 | 0.070(0.085, 0.040–0.172) | |
Smoking state | 0.476 | ||
Yes | 100 | 0.083(0.149,0.012-2.661) | |
No | 31 | 0.080(0.180, 0.019–1.367) | |
Censoring | 11 | 0.072(0.088, 0.040–0.172) | |
Drinking state | 0.216 | ||
Yes | 73 | 0.068(0.164, 0.013–2.661) | |
No | 58 | 0.090(0.146, 0.012–1.367) | |
Censoring | 11 | 0.072(0.088, 0.040–0.172) | |